These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4859718)

  • 1. Counting of particulate matter in parenteral solutions. I. Survey of the literature.
    Lines RW
    Bull Parenter Drug Assoc; 1967; 21(4):113-7. PubMed ID: 4859718
    [No Abstract]   [Full Text] [Related]  

  • 2. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 7. Counting of particulate matter in parenteral solutions. II. Particle counting in small containers.
    Lines RW
    Bull Parenter Drug Assoc; 1967; 21(4):118-23. PubMed ID: 6045457
    [No Abstract]   [Full Text] [Related]  

  • 8. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Particulate contamination of amino acid solutions for parenteral use].
    Ferrari F; Bonferoni MC; Zamella C; La Manna A; Verrengio B; Pedroni M; Omodei-Sale A
    Boll Chim Farm; 1991 Nov; 130(10):402-8. PubMed ID: 1805875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of particulate matter in parenteral solutions by image projection: A concept and its feasibility.
    Louer RC; Russoman JA; Rasanen PR
    Bull Parenter Drug Assoc; 1971; 25(2):54-64. PubMed ID: 5563316
    [No Abstract]   [Full Text] [Related]  

  • 12. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids.
    Ernerot L
    Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412
    [No Abstract]   [Full Text] [Related]  

  • 13. Particulate matter in I.V. infusion fluids.
    Davis NN; Turco S; Sivelly E
    Bull Parenter Drug Assoc; 1970; 24(6):257-70. PubMed ID: 5495399
    [No Abstract]   [Full Text] [Related]  

  • 14. Some factors influencing the measured content of particulate matter in infusion fluids.
    Ernerot L; Helmstein I; Sandell E
    Acta Pharm Suec; 1970 N0v; 7(5):501-8. PubMed ID: 5275181
    [No Abstract]   [Full Text] [Related]  

  • 15. Panel discussion: particulate matter. I. Prevention.
    Chertkoff MJ
    Bull Parenter Drug Assoc; 1966; 20(2):29-30. PubMed ID: 5905223
    [No Abstract]   [Full Text] [Related]  

  • 16. Panel discussion: particulate matter. 3. Electronic inspection.
    Levine S
    Bull Parenter Drug Assoc; 1966; 20(2):33-4. PubMed ID: 5905225
    [No Abstract]   [Full Text] [Related]  

  • 17. Theoretical aspects of particulate matter monitoring by microscopic and instrumental methods.
    Schroeder HG; Deluca PP
    J Parenter Drug Assoc; 1980; 34(3):183-91. PubMed ID: 6901774
    [No Abstract]   [Full Text] [Related]  

  • 18. An approach to setting particulate matter standards for small volume parenterals.
    DeLuca PP; Boddapati S; Haack D; Schroeder H
    J Parenter Sci Technol; 1986; 40(1):2-13. PubMed ID: 3701538
    [No Abstract]   [Full Text] [Related]  

  • 19. Panel discussion: particulate matter. II. Visual inspection.
    Saylor HM
    Bull Parenter Drug Assoc; 1966; 20(2):31-3. PubMed ID: 5905224
    [No Abstract]   [Full Text] [Related]  

  • 20. Panel discussion: particulate matter. IV. Toxicology.
    Brewer JH
    Bull Parenter Drug Assoc; 1966; 20(2):35-7. PubMed ID: 5905226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.